All relevant data are within the paper and its Supporting Information files. Additionally, whole-genome sequences were deposited in DDBJ/ENA/GenBank with the accession numbers CP018034 for Nagasaki and CP018032 for D74 genome and CP018033 for the plasmid sequence. These data have also been deposited in the REBASE database. The Haemophilus parasuis D74 are available at: <http://rebase.neb.com/cgi-bin/pacbioget?20940> and the Haemophilus parasuis Nagasaki data are available at: <http://rebase.neb.com/cgi-bin/pacbioget?20939>.

Introduction {#sec001}
============

*Haemophilus parasuis* is a small, Gram negative, non-motile, pleomorphic rod-shaped, and nicotinamide adenine dinucleotide (NAD)-dependent bacterium of the *Pasteurellaceae* family \[[@pone.0205700.ref001], [@pone.0205700.ref002]\]. *H*. *parasuis* is a respiratory pathogen affecting swine and is the etiological agent of Glässer\'s disease, a systemic infection resulting in arthritis, polyserositis (inflammation of serous membranes), and meningitis \[[@pone.0205700.ref002]--[@pone.0205700.ref004]\]. Additionally, *H*. *parasuis* infections can lead to pneumonia without signs of systemic disease in swine \[[@pone.0205700.ref005]--[@pone.0205700.ref007]\]. The morbidity and mortality caused by *H*. *parasuis* is a significant source of economic loss to the swine industry worldwide.

Serotyping based on the production of heat-stable antigens, in which capsular polysaccharide is presumed to be the dominant component of the serotyping antigen, is routinely used for isolate classification and epidemiological purposes as well as for guidance in regards to vaccination strategies. Fifteen serovars of *H*. *parasuis* have been defined, however, a substantial percentage of clinical isolates are identified as nontypeable (NT) using conventional indirect hemagglutination (IHA) methods \[[@pone.0205700.ref008], [@pone.0205700.ref009]\]. Progress to alleviate this problem has been made with the determination of the nucleotide sequence of the capsule locus from fifteen serovar reference isolates, which has been used to develop molecular serotyping methods \[[@pone.0205700.ref010]--[@pone.0205700.ref012]\].

*H*. *parasuis* isolates can exhibit different virulence capabilities ranging from lethal systemic disease to subclinical carriage. Numerous studies have focused on the identification of virulence factors that enable some isolates to cause systemic disease, distinguishing them from isolates that remain colonizers of the upper respiratory tract. Examples of potential virulence factors that have been evaluated to date include capsule production, outer membrane proteins (OMPs), trimeric autotransporters, and regulatory proteins QseC and OxyR \[[@pone.0205700.ref013]--[@pone.0205700.ref022]\]. Despite the advancement in our understanding of the pathogenic mechanisms used by *H*. *parasuis*, a direct link between specific virulence factors and the ability to cause systemic disease has not been demonstrated. Accordingly, virulence is thought to be multifactorial \[[@pone.0205700.ref002]--[@pone.0205700.ref004]\]. Data directly linking specific genes to disease outcomes has been hindered by several substantial complications, the most notable being difficulties in genetic modification of the chromosome due to low transformation efficiencies attributed to strain specific restriction modification barriers, as well as difficulties in consistently reproducing Glässer\'s disease in conventionally raised pigs due to confounding factors such as age, health status, differences in maternal antibody titers towards *H*. *parasuis*, and coinfection with other respiratory pathogens \[[@pone.0205700.ref023]--[@pone.0205700.ref026]\].

There are no effective approaches to eradicate *H*. *parasuis* from pig herds and controlling outbreaks has proven difficult \[[@pone.0205700.ref002], [@pone.0205700.ref027]\]. Although vaccines have been developed, most are comprised of bacterins, resulting in poor heterologous protection. Consequently no broadly protective vaccines or intervention strategies exist \[[@pone.0205700.ref028]--[@pone.0205700.ref030]\]. The current treatment for *H*. *parasuis* is broad spectrum antibiotics, which are expensive and are believed to increase the risk of resistant strain development \[[@pone.0205700.ref029], [@pone.0205700.ref031]--[@pone.0205700.ref033]\]. Additionally, with increased pressure to limit antibiotic use in agriculture, alternative approaches are desperately needed to reduce disease burden and economic losses caused by *H*. *parasuis*.

In a previous effort to link genomic differences to disease outcome, draft genome sequence data was obtained for ten genetically distinct isolates along with the evaluation of virulence in Caesarean-derived, colostrum deprived (CDCD) pigs \[[@pone.0205700.ref034]\]. These results demonstrated that strain D74 is a non-virulent colonizer of the upper respiratory tract, while in contrast, strain Nagasaki was highly virulent and capable of causing systemic disease \[[@pone.0205700.ref034]\]. Many genomic differences, including gene content and/or nucleotide variation, were identified that could account for the phenotypic difference between the strains \[[@pone.0205700.ref034]\]. Unfortunately many genes or regions of interest within each strain were incomplete, preventing a reliable one-to-one assignment and subsequent comparison of any predicted protein structure. In order to definitively identify and characterize the genomic differences between the highly virulent Nagasaki strain and the non-virulent D74 strain, the goal of our report was to obtain the closed whole-genome sequence and genome-wide methylation patterns between these phenotypically distinct strains.

Materials and methods {#sec002}
=====================

Genome sequencing and annotation {#sec003}
--------------------------------

*H*. *parasuis* strain Nagasaki is a Serotype Type 5 reference Strain and a Multilocus sequence typing (MLST) Type 24 strain. *H*. *parasuis* strain D74 is a Serotype Type 9 reference Strain and a MLST Type 25 strain. Strains were cultured in Brain Heart Infusion (BHI) Broth (BD Biosciences, Sparks, MD) supplemented with 5% filtered heat-inactivated horse serum (GIBCO, Life Technologies, Grand Island, NY) and 0.01% (w/v) nicotinamide adenine dinucleotide (NAD) (Sigma-Aldrich, St. Louis, MO) at 37°C in 5% CO~2~ for 24 hours and total genomic DNA was extracted using the High Pure PCR Template Preparation Kit (Roche Applied Science, Indianapolis, IN). Whole genome sequencing was performed using both the Pacific Biosciences (PacBio) and Illumina MiSeq platforms. Library preparation for PacBio sequencing was performed following the PacBio 10-kb insert library preparation protocol available online at (<http://www.pacb.com/wp-content/uploads/2015/09/Procedure-Checklist-10-kb-Template-Preparation-and-Sequencing.pdf>). The 10 kb library for each strain was sequenced using the PacBio RSII platform with two SMRT cells for each isolate. Indexed libraries for the MiSeq protocol were generated with the Nextera XT DNA sample preparation and index kits (Illumina, San Diego, CA), pooled, and sequenced using MiSeq v2 500-Cycle reagent kit yielding 2 x 250-bp paired-end reads (Illumina, San Diego, CA).

Whole genome assemblies were generated using the PacBio smrtanalysis v. 2.3.0 (<https://www.pacb.com/products-and-services/analytical-software/smrt-analysis/>) and CANU v. 1.3 \[[@pone.0205700.ref035]\] software. The average PacBio coverage for the assembled genomes was 805x for Nagasaki and 1,284x for D74. Assembling the PacBio data for each strain resulted in a fully sequenced closed circular chromosome, which was subsequently oriented to start at the *dnaA* gene and trimmed by removing any overlapping sequence. The genomes were then polished and error corrected using the Broad Institute's Pilon v 1.18 \[[@pone.0205700.ref036]\] and Illumina data 103x and 120x average coverage for Nagasaki and D74, respectively. The closed genome for each strain was then annotated using NCBI\'s Prokaryotic Genome Annotation Pipeline (PGAP) and additional curation was performed using the Prokka annotation software (version 1.12) \[[@pone.0205700.ref037]\] along with a *Haemophilus*-specific custom database. To compare putative protein sequences between Nagasaki and D74, the RAST prokaryotic genome annotation server \[[@pone.0205700.ref038]\] (<http://rast.nmpdr.org/>) was used to map annotated protein coding sequences (CDS) to functional subsystems and performed a one-to-one BLASTP comparison between the strains. Genome organization was evaluated using the Artemis Comparison Tool \[[@pone.0205700.ref039]\] and Mauve \[[@pone.0205700.ref040]\].

Plasmid sequencing and annotation {#sec004}
---------------------------------

Assembled PacBio data for pD74 did not initially result in a circularized plasmid sequence. The complete nucleotide sequence was subsequently determined using a primer walking strategy employing five separate plasmid preparations isolated from strain D74 using a Wizard Plus SV Minipreps DNA Purification System (Promega, Madison, WI) according to the manufacturer\'s protocol. The resulting circularized plasmid sequence was then polished and error corrected using the Broad Institute's Pilon v 1.18 \[[@pone.0205700.ref036]\] and Illumina data 104x average coverage for strain D74. The assembled pD74 sequence was then annotated using NCBI\'s Prokaryotic Genome Annotation Pipeline (PGAP). Further sequence analysis was carried out using BLASTN, BLASTX, and Tandem Repeats Finder \[[@pone.0205700.ref041]\].

IS and CRISPR analysis {#sec005}
----------------------

Genomes were submitted to ISfinder (<https://www-is.biotoul.fr/>) \[[@pone.0205700.ref042]\] for the identification of bacterial IS elements using default parameters. Genomes were submitted to CRISPRFinder (<http://crispr.i2bc.paris-saclay.fr/Server/>) \[[@pone.0205700.ref043]\] for the identification CRISPR elements using default parameters.

Phenotypic analysis {#sec006}
-------------------

Phenotypic antibiotic resistance was determined using the broth microdilution method by Iowa State University Veterinary Diagnostic Laboratory following standard operating procedures. Each isolate was tested using the Trek BOPO6F plate (Thermo Fisher Scientific Inc., Oakwood Village, OH) and minimum inhibitory concentrations (MICs) were determined. MICs were evaluated in accordance with Clinical Laboratory Standards Institute (CLSI) recommendations for resistance interpretations.

Genomic antimicrobial resistance (AMR) analysis {#sec007}
-----------------------------------------------

ResFinder 2.1 from the Center for Genomic Epidemiology (<http://www.genomicepidemiology.org/>) and the Comprehensive Antibiotic Resistance Database (CARD) (<https://card.mcmaster.ca/home>) were employed for AMR determinant identification. Genomes submitted to ResFinder 2.1 were evaluated for AMR determinants using starting parameters of a threshold ID of 90% and a minimum length of 60% and final parameters of a threshold ID of 30% and a minimum length of 20%. Genomes submitted to CARD were evaluated for AMR determinants using the criteria "default--perfect and strict hits only".

Capsular loci analysis {#sec008}
----------------------

The nucleotide sequences of genes within the capsule loci of Nagasaki and D74 reported by Howell et al. \[[@pone.0205700.ref010]\] were obtained from NCBI. Alignments of individual gene and protein sequences, as well as calculation of percent identities, were performed using the Geneious Alignment tool in Geneious 10.1.3 (Biomatters Ltd., Auckland, New Zealand). Global alignment with free end gaps parameters were used for both nucleotide and protein sequence alignments followed by determining the percent identity relative to Howell et al. \[[@pone.0205700.ref010]\]. Nucleotide and amino acid insertions are reported using HGVS nomenclature \[[@pone.0205700.ref044]\].

*cdiA* gene analysis {#sec009}
--------------------

The nucleotide sequences of genes within the *cdiA* region of D74 were evaluated using BLASTX. Translated coding sequences were extracted and evaluated for the occurrence of any domain using the Pfam 31.0 database (<https://pfam.xfam.org/>) \[[@pone.0205700.ref045]\].

*vtaA* gene analysis {#sec010}
--------------------

To ensure that all potential *vtaA* genes were identified in both Nagasaki and D74 genome annotations, the translated coding sequences were extracted and batch queried using the Pfam 31.0 database (<https://pfam.xfam.org/>) \[[@pone.0205700.ref045]\] for all occurrences of a YadA_anchor domain (PF03895) \[[@pone.0205700.ref015]\]. Geneious 10.1.3 (Biomatters Ltd., Auckland, New Zealand) was employed to evaluate and compare the genome location of *vtaA* genes in both Nagasaki and D74, including flanking upstream and downstream genes. The domain architecture and content of each *vtaA* gene from both Nagasaki and D74 was further evaluated for the occurrence of any domains using the Pfam 31.0 database (<https://pfam.xfam.org/>) \[[@pone.0205700.ref045]\]. BLASTN was employed to search sequences upstream of *vtaA* genes in both Nagasaki and D74 for the occurrence of the Nagasaki *vtaA4* promoter sequence identified by Pina et al. \[[@pone.0205700.ref015]\].

Methylation analysis {#sec011}
--------------------

Detection of modified bases (m6A, m4C, m5C) and clustering of modified sites to identify methylation associated motifs was performed using the RS_Modification_and_Motif_analysis.1 tool from the SMRT analysis package version 2.3.0. Briefly, raw reads were aligned to the complete genomes of D74 and Nagasaki and interpulse duration (IPD) ratios were measured for all pulses aligned to each position in the reference sequence (<http://www.pacb.com/pdf/TN_Detecting_DNA_Base_Modifications.pdf>). \[[@pone.0205700.ref046]\]

SSR analysis {#sec012}
------------

The nucleotide sequences of all putative RM genes identified in D74 and Nagasaki were evaluated for the occurrence of SSRs, tandem repeats or homopolymeric tracts of consisting of five or more bases, within the coding region and in the region encompassing 150 bp upstream of the putative start codon using Geneious 10.1.3 (Biomatters Ltd., Auckland, New Zealand).

Accession number(s) {#sec013}
-------------------

The whole-genome sequences for these isolates were deposited in DDBJ/ENA/GenBank with the accession numbers CP018034 for Nagasaki and CP018032 for D74 genome and CP18033 for the plasmid sequence. The sequence data, target sequences and associated details for methylation enzymes, used for analyses in this report have been deposited in the REBASE database ([www.rebase.neb.com](http://www.rebase.neb.com/)) \[[@pone.0205700.ref047]\]. RM-system and methylation motifs for both strains can be accessed via the index of the REBASE database (<http://tools.neb.com/genomes/>) or directly via this link: <http://rebase.neb.com/cgi-bin/pacbioget?20940> for D74 or <http://rebase.neb.com/cgi-bin/pacbioget?20939> for Nagasaki.

Results and discussion {#sec014}
======================

Genome features of *H*. *parasuis* strains D74 and Nagasaki {#sec015}
-----------------------------------------------------------

The complete genome assembly and annotation of *H*. *parasuis* strain Nagasaki contains a single circular chromosome 2,348,962 base pairs (bp) in length, encodes a total of 2,268 predicted protein coding sequences (CDSs), and a G+C content of 40.0% ([Table 1](#pone.0205700.t001){ref-type="table"}). Of the 2,268 CDSs, 95 were predicted to be pseudogenes. The complete genome assembly and annotation of *H*. *parasuis* strain D74 encompasses a single circular chromosome 2,467,568 base pairs (bp) in length, a total of 2,252 total predicted protein coding sequences (CDSs), and a G+C content of 39.7% ([Table 1](#pone.0205700.t001){ref-type="table"}). Similar to Nagasaki, 95 out of the 2,252 CDSs were predicted to be pseudogenes. Despite the equivalent number, none of the predicted pseudogenes were similar between the stains ([S1 Table](#pone.0205700.s001){ref-type="supplementary-material"} and [S2 Table](#pone.0205700.s002){ref-type="supplementary-material"}). The difference in rRNA numbers between D74 and Nagasaki is consistent with other closed *H*. *parasuis* genomes available in GenBank ([Table 1](#pone.0205700.t001){ref-type="table"}). The genomes of *H*. *parasuis* Nagasaki and D74 were assessed using PHASTER (<http://phaster.ca/>) \[[@pone.0205700.ref048]\] for the occurrence of phage regions. Nine phage regions, seven intact and two incomplete, were identified along the Nagasaki chromosome ([Table 2](#pone.0205700.t002){ref-type="table"}). Six phage regions, one intact and five incomplete, were also identified along the D74 chromosome ([Table 1](#pone.0205700.t001){ref-type="table"}). The phage regions identified are unique to each genome. The chromosomal location, including start and end nucleotide positions, length of phage region, and classification of phage regions for both strains are summarized in [Table 2](#pone.0205700.t002){ref-type="table"}.

10.1371/journal.pone.0205700.t001

###### General features of the genomes of *H*. *parasuis* strains D74 and Nagasaki.

![](pone.0205700.t001){#pone.0205700.t001g}

  ---------------------------------------------------------------------------
                                                      D74         Nagasaki
  --------------------------------------------------- ----------- -----------
  Sequence\                                           9           5
  Type (ST)                                                       

  **Chromosome Size (bp)**                            2,467,568   2,348,962

  G + C Content (%)                                   39.7%       40.0%

  **Total CDSs**                                      2,252       2,268

  Pseudogenes[^a^](#t001fn001){ref-type="table-fn"}   95          95

  **Functional CDSs**                                 2,157       2,173

  rRNA (16S-23S-5S)                                   6-6-7       6-6-8

  **tRNA**                                            57          60

  Phage Regions                                       6           9

  Plasmid                                             1           0
  ---------------------------------------------------------------------------

^a^Encoding either an incomplete predicted protein sequence, a frameshift, or an internal stop codon.

10.1371/journal.pone.0205700.t002

###### Phage regions identified in *H*. *parasuis* strains D74 and Nagasaki.

![](pone.0205700.t002){#pone.0205700.t002g}

  Strain     Region \#   Start[^a^](#t002fn001){ref-type="table-fn"}   End[^a^](#t002fn001){ref-type="table-fn"}   Length[^b^](#t002fn002){ref-type="table-fn"}   Classification[^c^](#t002fn003){ref-type="table-fn"}
  ---------- ----------- --------------------------------------------- ------------------------------------------- ---------------------------------------------- ------------------------------------------------------
  Nagasaki   1           75,146                                        95,579                                      20,434                                         Incomplete
  2          578,665     613,918                                       35.254                                      Intact                                         
  3          930,933     982,262                                       51.330                                      Intact                                         
  4          978,209     1,022,173                                     43,965                                      Intact                                         
  5          1,146,622   1,187,091                                     40,470                                      Intact                                         
  6          1,837,359   1,870,441                                     33,083                                      Intact                                         
  7          1,890,250   1,901,023                                     10,774                                      Incomplete                                     
  8          2,053,720   2,085,576                                     31,857                                      Intact                                         
  9          2,113,966   2,153,632                                     39,667                                      Intact                                         
  D74        1           1,021,542                                     1,030,153                                   8,612                                          Incomplete
  2          1,179,090   1,197,266                                     18,177                                      Incomplete                                     
  3          1,186,455   1,216,786                                     30,332                                      Incomplete                                     
  4          1,303,971   1,339,245                                     35,275                                      Intact                                         
  5          1,390,803   1,407,651                                     16,840                                      Incomplete                                     
  6          1,868,288   1,889,812                                     21,525                                      Incomplete                                     

^a^Basepair chromosomal location.

^b^Length of region depicted in base pairs.

^c^Classification determined by PHASTER analysis (<http://phaster.ca/>) \[[@pone.0205700.ref048]\].

An 11,595-bp circular plasmid was additionally identified in the complete genome assembly and annotation of *H*. *parasuis* strain D74. With the addition of the plasmid, the total nucleotides, including both the circular chromosome and plasmid, is 2,479,163 bp for strain D74. The plasmid harbored by strain D74, designated as pD74, contains seven CDSs with predicted functions based on sequence homology, including *parA*, *rec*, and *repB*, which have predicted functions in plasmid replication. Additionally, pD74 harbors six CDSs of unknown function and one predicted pseudogene ([Fig 1](#pone.0205700.g001){ref-type="fig"}). These CDSs lacked a reciprocal match in Nagasaki. A region containing four copies of a 22-bp tandem repeat sequence was identified upstream of the *repB* CDS, which could potentially comprise the origin of replication ([Fig 1](#pone.0205700.g001){ref-type="fig"}). The sequence spanning from 3,328 to 1,243 bp comprises the entire 9,462 bp sequence of *H*. *parasuis* plasmid pHS-Rec (accession no. AY862436) with 99.2% sequence identity ([Fig 1](#pone.0205700.g001){ref-type="fig"}) \[[@pone.0205700.ref049]\]. The sequence spanning from 5,847 to 1,025 bp shares 99.4% sequence identity with *Pasteurella trehalosi* plasmid pCCK13698 (accession no. AM183225) ([Fig 1](#pone.0205700.g001){ref-type="fig"}) \[[@pone.0205700.ref050]\]. pD74 sequencing from 1,246 to 5,350 bp shares 73.9% sequence identity with a chromosomal region of *Gallibacterium anantis* strain UMN179 (accession no. CP002667) ([Fig 1](#pone.0205700.g001){ref-type="fig"}) \[[@pone.0205700.ref051]\].

![Map of plasmid pD74.\
Arrows indicate annotated CDSs; blue arrows represent CDSs with predicted functions based on sequence homology, pink arrows represent predicted CDSs of unknown function. The MFS transporter gene, labeled with a blue-grey arrow, is predicted to be a pseudogene. Dark grey box indicates region containing 4 copies of a 22-bp tandem repeat sequence identified using the Tandem Repeats Finder tool \[[@pone.0205700.ref041]\]. Arcs inside map indicate sequence with similarity to other sources; green arc represents sequence similar to *H*. *parasuis* plasmid pHS-Rec \[[@pone.0205700.ref049]\], purple arc represents sequence similar to a portion of the *Pasteurella trehalosi* plasmid pCCK13698 \[[@pone.0205700.ref050]\], and yellow arc represents sequence similar to a region from the genome sequence of *Gallibacterium anantis* strain UMN179 \[[@pone.0205700.ref051]\].](pone.0205700.g001){#pone.0205700.g001}

Comparison of the genome sequences of *H*. *parasuis* strains D74 and Nagasaki {#sec016}
------------------------------------------------------------------------------

A reciprocal or one-to-one BLASTP comparison of the protein coding sequences in Nagasaki and D74 identified 1,705 shared CDSs between the strains ([Fig 2](#pone.0205700.g002){ref-type="fig"}). Of the 2,173 functional CDSs in strain Nagasaki, 366 CDSs lacked a reciprocal match in D74 and were designated unique or Nagasaki-specific ([Fig 2A](#pone.0205700.g002){ref-type="fig"}). Conversely, 324 CDSs, out of the 2,157 functional CDSs in strain D74, lacked a reciprocal match in Nagasaki and were designated unique or D74-specific ([Fig 2A](#pone.0205700.g002){ref-type="fig"}). Comparison of the linear organization of the genomes of Nagasaki and D74 revealed many genome re-arrangements and inversions ([Fig 2B](#pone.0205700.g002){ref-type="fig"}). The alignment additionally resulted in 73 locally collinear blocks (LCBs), the largest of which is 520,607 bp ([Fig 2B](#pone.0205700.g002){ref-type="fig"}).

![Comparison of the genome sequences of *H*. *parasuis* strains D74 and Nagasaki.\
(A) Distribution of protein-encoding genes in *H*. *parasuis* strains Nagasaki and D74. Venn diagram demonstrating the unique 2,173 protein-encoding genes in Nagasaki (blue), the 2,157 protein-encoding genes D74 (yellow), and the shared coding sequences defined as bi-directional best hits (center circle, green) via 1-to-1 reciprocal BLASTP comparison using RAST \[[@pone.0205700.ref038]\] (excluding frame-shifted genes). (B) Comparison of the linear organization of the *H*. *parasuis* strains Nagasaki and D74 chromosomes. Mauve \[[@pone.0205700.ref040]\] was used to compare the chromosomes of Nagasaki and D74. Locally collinear blocks (LCBs) representing regions of sequence that align in each genome are illustrated as colored rectangles connected by lines. Nagasaki was used as the reference sequence. In D74, LCBs placed above the center line are in the same orientation as in Nagasaki and LCBs placed below the center line are in the reverse orientation relative to Nagasaki. Blank sections are regions that did not align and are likely to contain unique or strain-specific sequence. Many of the larger blank regions not in LCBs contain loci predicted to encode products of phage origin.](pone.0205700.g002){#pone.0205700.g002}

The genomes of *H*. *parasuis* Nagasaki and D74 were assessed for the presence of insertion sequence (IS) elements using ISfinder (<https://www-is.biotoul.fr/>) \[[@pone.0205700.ref042]\]. IS elements found previously in other *H*. *parasuis* and *Pasteurellaceae* genomes were identified in both D74 and Nagasaki genomes and these IS elements contained the greatest similarity to sequences from the IS*1595* family. Specifically, four IS*Hps3* and three IS*Hps4* IS elements were identified in D74, while one IS*Hps3* and four IS*Hps4* IS elements were identified in Nagasaki. *In silico* analysis revealed the occurrence of additional transposases annotated as belonging to other families, such as IS*256* and IS*110*, in both D74 and Nagasaki genomes that were not identified by ISfinder analysis, given that it typically does not identify frameshifted or truncated IS units. These transposases were annotated as pseudogenes and therefore are likely nonfunctional. Of the five complete IS units identified in Nagasaki, two are within regions of conserved sequence order and have homologs in D74. Three of the intact IS units identified in Nagasaki are located at the border of sequence rearrangement, with one located at the border of one of the phage regions. Six complete IS units were identified in D74 with two located at the border of rearranged regions. Of the four IS units that are present within regions of conserved sequence order, two are within regions of conserved sequence order and have homologs in Nagasaki and two are small sequence insertions located within a conserved region in which only the IS unit is the only sequence not conserved within the region. Clusters of regularly interspaced short palindromic repeats (CRISPR) and spacer sequences in the genomes of both D74 and Nagasaki were screened using CRISPRFinder ([http://crispr.i2bc.paris-saclay.fr](http://crispr.i2bc.paris-saclay.fr/)) \[[@pone.0205700.ref043]\]. No evidence for CRISPR sequences were found in either genome.

Phenotypic antibiotic resistance was determined for *H*. *parasuis* D74 and Nagasaki and results are summarized in [S3 Table](#pone.0205700.s003){ref-type="supplementary-material"}. Nagasaki exhibited phenotypic resistance to clindamycin while D74 exhibited "intermediate" limited phenotypic resistance to clindamycin; no other resistance was identified. The genomes of *H*. *parasuis* Nagasaki and D74 were screened for the presence of acquired resistance genes and known chromosomal mutations conferring clindamycin resistance. No *erm*, *lnu*, or other known resistance determinants were identified in either genome.

Capsule loci in *H*. *parasuis* strains D74 and Nagasaki {#sec017}
--------------------------------------------------------

Due to the importance of capsular polysaccharide in serotyping or strain classification, virulence, and vaccine related research areas, the CDSs located within the capsule loci of Nagasaki and D74 were compared to nucleotide sequences reported by Howell et al. \[[@pone.0205700.ref010]\]. Several nucleotide and amino acid differences were identified and are summarized in [S4 Table](#pone.0205700.s004){ref-type="supplementary-material"} and [S5 Table](#pone.0205700.s005){ref-type="supplementary-material"}. Eleven out of sixteen predicted proteins within the D74 capsule locus were found to contain amino acid differences compared to the sequences reported by Howell et al. \[[@pone.0205700.ref010]\]. The genes harboring the most or more noteworthy changes for D74 include *wzx2*, *astA*, *gltL*, and *wzs* ([S4 Table](#pone.0205700.s004){ref-type="supplementary-material"}). The predicted amino acid changes in AstA relative to the Howell et al. \[[@pone.0205700.ref010]\] sequence included a two amino acid insertion and are: N98_H99insHId, Q134R, S157A, V177I, V183I, I189V, S195N, and V2056M. In contrast, the predicted amino acid sequence for GltL is shorter than that reported in Howell et al. \[[@pone.0205700.ref010]\] due to a different predicted start codon. The predicted amino acid changes in GltL are M1_K8del and V9M. The predicted amino acid changes in Wzx2 relative to the Howell et al. \[[@pone.0205700.ref010]\] sequence are: V176A, I180V, A187V, S192N, R278H, P291S, and R373S ([S4 Table](#pone.0205700.s004){ref-type="supplementary-material"}). The predicted amino acid changes in Wzs relative to the Howell et al. \[[@pone.0205700.ref010]\] sequence are: E3K, L27I, V230A, V613A, and V622A ([S4 Table](#pone.0205700.s004){ref-type="supplementary-material"}).

In *H*. *parasuis* Nagasaki, twelve out of fourteen predicted proteins within the capsule locus were found to contain amino acid differences compared to the sequences reported by Howell et al. \[[@pone.0205700.ref010]\]. The genes harboring the more notable changes for Nagasaki include *funA*, *wcfQ*, and *wbgX* ([S5 Table](#pone.0205700.s005){ref-type="supplementary-material"}). FunA is predicted to result in a longer protein sequence compared to Howell et al. \[[@pone.0205700.ref010]\] due to a different predicted start codon and five amino acid changes within the shared region, along with 37 additional amino acids on the N-terminus. The predicted amino acid changes in FunA are M1ext-37, A2V, A6V, D27V, S28N, and V138I ([S5 Table](#pone.0205700.s005){ref-type="supplementary-material"}). The predicted amino acid changes in WcfQ relative to the Howell et al. \[[@pone.0205700.ref010]\] sequence are: E43K, I58V, S61T, I64T, F106S, D131G, F132S, N194K, Y262C, R269N, F270N, and L271F ([S5 Table](#pone.0205700.s005){ref-type="supplementary-material"}). WbgX is predicted to encode a shorter protein sequence compared to Howell et al. \[[@pone.0205700.ref010]\] due to a different predicted start codon. The predicted amino acid changes in WbgX are: M1del, K2M, E3N, F4Y, T177A, S343N, P344A, and A349I ([S5 Table](#pone.0205700.s005){ref-type="supplementary-material"}).

Virulence-associated genes identified in *H*. *parasuis* strains D74 and Nagasaki {#sec018}
---------------------------------------------------------------------------------

To identify factors that could support host colonization and/ or virulence, the D74 and Nagasaki annotations were searched for CDSs encoding predicted functions in adhesion, hemolysis, secretion, toxin production, or other virulence-associated roles. Twenty-one CDSs encoding predicted adhesins were identified in D74 including five outer membrane genes (*ompA*, *ompP1*, *ompP2*, *ompP5*, and *ompD15*), two *fimD* fimbrial usher genes located adjacent to each other along the chromosome, pertactin family virulence factor *aidA*, filamentous hemagglutinin transporter *fhaC*, adhesin autotransporter *bmaC*, and two type IV pili genes ([Table 3](#pone.0205700.t003){ref-type="table"}). Corresponding orthologs for *pilT* and *bmaC* were not found in Nagasaki. Gene *leuC* (A2U21_06460) in Nagasaki was the uni-directional best match to *pilT* (A2U20_03770) in D74 with 56% global nucleotide sequence identity and gene *aidA2* (A2U21_04065) in Nagasaki was the uni-directional best match to *bmaC* (A2U20_08910) in D74 with 51% global nucleotide sequence identity ([Table 3](#pone.0205700.t003){ref-type="table"}). Eighteen CDSs encoding predicted adhesins were identified in Nagasaki including five outer membrane genes (*ompA*, *ompP1*, *ompP2*, *ompP5*, and *ompD15*), one *fimD* fimbrial usher gene (chromosomally adjacent to a predicted pseudogene *fimB*), two pertactin family virulence factor genes *aidA* and *aidA2*, and two type IV pili ([Table 4](#pone.0205700.t004){ref-type="table"}). *In silico* analysis of the region in D74 containing the two *fimD* genes compared to the *fimD* gene in Nagasaki indicated that the D74 *fimD2* (A2U20_08925) aligns with the 5' end of the Nagasaki *fimD* (A2U21_03995) and the D74 *fimD* (A2U20_08920) aligns with the 3' end of the Nagasaki *fimD* gene. This suggests that the two *fimD* genes in D74 could have potentially arisen from a frameshift within a single gene. A 51% sequence identity was observed between corresponding orthologs *esiB* (A2U20_01865) in D74 and *esiB2* (A2U21_08055) in Nagasaki ([Table 3](#pone.0205700.t003){ref-type="table"} and [Table 4](#pone.0205700.t004){ref-type="table"}).

10.1371/journal.pone.0205700.t003

###### Predicted virulence-associated genes identified in *H*. *parasuis* D74.

![](pone.0205700.t003){#pone.0205700.t003g}

  Group       D74 locus_tag   D74 Name   Product/ Function                                        Hit[^a^](#t003fn001){ref-type="table-fn"}   Nagasaki locus_tag   \% Identity[^b^](#t003fn002){ref-type="table-fn"}
  ----------- --------------- ---------- -------------------------------------------------------- ------------------------------------------- -------------------- ---------------------------------------------------
  Adhesin     A2U20_02695     *pilW*     Type IV pilus biogenesis/stability protein PilW          bi                                          A2U21_08925          100
              A2U20_03215     *pulG*     Type II secretory pathway, pseudopilin PulG              bi                                          A2U21_08415          97
              A2U20_03220     *pulJ*     Type II secretory pathway, component PulJ                bi                                          A2U21_08410          96
              A2U20_03425     *pilM*     Type IV pilus biogenesis protein PilM                    bi                                          A2U21_08215          98
              A2U20_03430     *pilN*     Type IV pilus biogenesis protein PilN                    bi                                          A2U21_08210          98
              A2U20_03445     *pilQ*     Type IV pilus biogenesis PilQ                            bi                                          A2U21_08195          94
              A2U20_03490     *ompP5*    Outer membrane protein P5                                bi                                          A2U21_08150          92
              A2U20_03710     *ompP1*    Outer membrane protein precursor P1                      bi                                          A2U21_07950          90
              A2U20_03770     *pilT*     pilT domain-containing protein                           uni                                         A2U21_06460          56
              A2U20_04380     *ompP2*    Outer membrane protein P2 precursor                      bi                                          A2U21_07315          85
              A2U20_04655     *ompD15*   Surface antigen (D15), outer membrane protein            bi                                          A2U21_07040          99
              A2U20_04855     *ompA*     Outer membrane protein A                                 bi                                          A2U21_06820          98
              A2U20_06825     *fhaC*     Filamentous hemagglutinin transporter protein FhaC       uni                                         A2U21_11135          52
              A2U20_07210     *pilA*     Type IV pilin PilA                                       bi                                          A2U21_10860          87
              A2U20_07215     *pilB*     Type IV fimbrial assembly ATPase PilB                    bi                                          A2U21_10855          98
              A2U20_07220     *pilC*     Type IV fimbrial assembly protein PilC                   bi                                          A2U21_10850          99
              A2U20_07225     *pilD*     Tfp pilus assembly pathway, fimbrial leader peptidase    bi                                          A2U21_10845          94
              A2U20_08340     *aidA*     Type V secretory pathway, adhesin AidA                   bi                                          A2U21_04065          72
              A2U20_08910     *bmaC*     Adhesin BmaC autotransporter                             uni                                         A2U21_04065          51
              A2U20_08920     *fimD*     Putative F17-like fimbrial usher                         uni                                         A2U21_03995          98
              A2U20_08925     *fimD2*    Putative F17-like fimbrial usher                         bi                                          A2U21_03995          99
  Hemolysin   A2U20_02515     *prtC*     Serralysin C                                             uni                                         A2U21_00470          58
              A2U20_06885                Hemagglutinin/hemolysin-related protein                  \-                                                               
              A2U20_07380     *hlyD*     Hemolysin secretion protein D                            \-                                                               
              A2U20_08300     *shlB*     Hemolysin transporter protein ShlB                       bi                                          A2U21_11135          53
              A2U20_08375     *osmY*     Osmotically-inducible protein OsmY; putative hemolysin   bi                                          A2U21_04100          100
              A2U20_09890     *ahpA*     Hemolysin regulation protein AhpA                        bi                                          A2U21_02620          99
              A2U20_10965     *prtB*     Serralysin B, hemolysin-type calcium-binding region      uni                                         A2U21_00470          56
              A2U20_10970     *prtB2*    Serralysin B, hemolysin-type calcium-binding region      bi                                          A2U21_00470          69
  Secretion   A2U20_01865     *esiB*     Putative secretory immunoglobulin A-binding protein      bi                                          A2U21_08055          51
              A2U20_09675                Putative periplasmic/secreted protein                    bi                                          A2U21_02375          93
  Toxin       A2U20_00255     *ebgC*     EbgC protein_Toxin-antitoxin biofilm protein TabA        bi                                          A2U21_00620          98
              A2U20_01495     *higA*     Antitoxin HigA_mRNA interferase antitoxin                uni                                         A2U21_00995          63
              A2U20_01500     *hicA*     Addiction module toxin HicA                              uni                                         A2U21_01000          59
              A2U20_01850     *vapC*     VapC toxin family PIN domain ribonuclease                bi                                          A2U21_10000          78
              A2U20_02115     *hipA*     Serine/threonine-protein kinase toxin HipA               bi                                          A2U21_09500          95
              A2U20_02705     *higA2*    Antitoxin HigA_mRNA interferase antitoxin                bi                                          A2U21_08915          93
              A2U20_02710     *higB*     mRNA interferase toxin HigB                              bi                                          A2U21_08910          96
              A2U20_02805     *tdeA*     Putative toxin and drug export protein A                 bi                                          A2U21_08785          97
              A2U20_02840     *relE*     Addiction module toxin RelE                              bi                                          A2U21_03035          59
              A2U20_03250     *mazF*     Programmed cell death toxin MazF                         uni                                         A2U21_06190          52
              A2U20_03635     *hicA2*    Aaddiction module toxin HicA                             bi                                          A2U21_02950          94
              A2U20_04570     *higA3*    Antitoxin HigA_mRNA interferase antitoxin                uni                                         A2U21_00995          63
              A2U20_04795     *pezT*     Antitoxin/toxin system zeta toxin                        uni                                         A2U21_03130          53
              A2U20_04825     *cdtC*     Cytolethal distending toxin subunit CdtC                 bi                                          A2U21_06570          99
              A2U20_04830     *cdtB*     Cytolethal distending toxin subunit CdtB                 uni                                         A2U21_06565          95
              A2U20_04835     *cdtA*     Cytolethal distending toxin subunit CdtA                 bi                                          A2U21_06560          99
              A2U20_04880     *higB2*    mRNA interferase toxin HigB                              uni                                         A2U21_05325          55
              A2U20_04885     *higA4*    Antitoxin HigA_mRNA interferase antitoxin                uni                                         A2U21_08915          56
              A2U20_05030     *higA5*    Antitoxin HigA_mRNA interferase antitoxin                bi                                          A2U21_06130          98
              A2U20_05035     *higB3*    mRNA interferase toxin HigB                              bi                                          A2U21_06135          99
              A2U20_05120     *cdtC2*    Cytolethal distending toxin subunit CdtC                 uni                                         A2U21_06570          98
              A2U20_05125     *cdtB2*    Cytolethal distending toxin subunit CdtB                 bi                                          A2U21_06565          96
              A2U20_05130     *cdtA2*    Cytolethal distending toxin subunit CdtA                 uni                                         A2U21_06560          99
              A2U20_05385     *higA6*    Antitoxin HigA_mRNA interferase antitoxin                bi                                          A2U21_06310          99
              A2U20_05390     *higB4*    mRNA interferase toxin HigB                              bi                                          A2U21_06305          100
              A2U20_05455     *higB5*    mRNA interferase toxin HigB                              bi                                          A2U21_06250          99
              A2U20_05460     *higA7*    Antitoxin HigA_mRNA interferase antitoxin                bi                                          A2U21_06245          100
              A2U20_05480     *cdiA*     Contact-dependent growth inhibition (CDI) toxin          \-                                                               
              A2U20_05555     *chpS*     Antitoxin ChpS                                           bi                                          A2U21_06185          99
              A2U20_05585     *tabA*     Toxin-antitoxin biofilm protein TabA                     bi                                          A2U21_06150          100
              A2U20_05690     *hicA3*    Addiction module toxin HicA                              bi                                          A2U21_04705          62
              A2U20_06620     *higA8*    Antitoxin HigA_mRNA interferase antitoxin                bi                                          A2U21_05330          93
              A2U20_06625     *higB6*    mRNA interferase toxin HigB                              bi                                          A2U21_05325          99
              A2U20_06830     *cdiA2*    Contact-dependent growth inhibition (CDI) toxin          \-                                                               
              A2U20_06850     *cdiA3*    Contact-dependent growth inhibition (CDI) toxin          \-                                                               
              A2U20_06865     *cdiA4*    Contact-dependent growth inhibition (CDI) toxin          \-                                                               
              A2U20_06875     *cdiA5*    Contact-dependent growth inhibition (CDI) toxin          \-                                                               
              A2U20_07065     *pezT2*    Antitoxin/toxin system zeta toxin                        bi                                          A2U21_03130          75
              A2U20_07375     *ltxB*     Leukotoxin export ATP-binding protein LtxB               uni                                         A2U21_07020          52
              A2U20_08285     *cdiA6*    Contact-dependent growth inhibition (CDI) toxin          \-                                                               
              A2U20_08295     *cdiA7*    Contact-dependent growth inhibition (CDI) toxin          \-                                                               
              A2U20_08515     *pasI*     Persistence and stress-resistance antitoxin PasI         bi                                          A2U21_04275          98
              A2U20_10085     *hicB*     Antitoxin HicB                                           bi                                          A2U21_00970          100
              A2U20_10110     *higA9*    Antitoxin HigA_mRNA interferase antitoxin                bi                                          A2U21_00995          98
              A2U20_10115     *higB7*    mRNA interferase toxin HigB                              bi                                          A2U21_01000          99
              A2U20_10565     *hipA2*    Serine/threonine-protein kinase toxin HipA               bi                                          A2U21_00565          99
  Other       A2U20_00515     *nanH*     Sialidase                                                bi                                          A2U21_11540          99
              A2U20_01700     *espP*     Putative extracellular serine protease                   bi                                          A2U21_09655          75
              A2U20_01715     *espP2*    Putative extracellular serine protease                   bi                                          A2U21_09640          78
              A2U20_03355     *vacJ*     Putative VacJ lipoprotein                                bi                                          A2U21_08285          97
              A2U20_05150     *sirA*     Regulator of disulfide bond formation                    bi                                          A2U21_06540          99
              A2U20_05155     *sirB*     Invasion protein expression up-regulator SirB            bi                                          A2U21_06535          100
              A2U20_07890     *sodA*     Superoxide dismutase                                     bi                                          A2U21_03770          100
              A2U20_08325     *sodC*     Superoxide dismutase                                     bi                                          A2U21_04050          92

^a^ The Hit column contains a \'-\' (no hit), \'uni\' or \'bi\' RAST server results from a one-to-one BLASTP comparison of the protein coding sequences in the Nagasaki genome using the D74 genome as the reference. "bi" represents a bidirectional best hit in which the reverse hit from the Nagasaki comparison genome to the D74 reference genome was also the best hit. "uni" indicates a uni-directional hit in which the reverse hit from the comparison genome to the reference genome was not also the best hit. "-"indicates no hit or match was found.

^b^Global pairwise nucleotide percent sequence identity.

10.1371/journal.pone.0205700.t004

###### Predicted virulence-associated genes identified in *H*. *parasuis* Nagasaki.
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  Group         Nagasaki locus_tag   Nagasaki Name   Product/ Function                                                  Hit[^a^](#t004fn001){ref-type="table-fn"}   D74 locus_tag   \% Identity[^b^](#t004fn002){ref-type="table-fn"}
  ------------- -------------------- --------------- ------------------------------------------------------------------ ------------------------------------------- --------------- ---------------------------------------------------
  Adhesin       A2U21_02720          *aidA*          Type V secretory pathway, adhesin AidA                             \-                                                          
                A2U21_03995          *fimD*          Putative F17-like fimbrial usher                                   bi                                          A2U20_08925     99
                A2U21_04065          *aidA2*         Type V secretory pathway, adhesin AidA                             bi                                          A2U20_08340     72
                A2U21_06820          *ompA*          Outer membrane protein A precursor                                 bi                                          A2U20_04855     98
                A2U21_07040          *ompD15*        Surface antigen (D15), outer membrane protein                      bi                                          A2U20_04655     99
                A2U21_07315          *ompP2*         Outer membrane protein P2 precursor                                bi                                          A2U20_04380     85
                A2U21_07950          *ompP1*         Outer membrane protein precursor P1                                bi                                          A2U20_03710     90
                A2U21_08150          *ompP5*         putative outer membrane protein P5                                 bi                                          A2U20_03490     92
                A2U21_08195          *pilQ*          Type IV pilus biogenesis protein PilQ                              bi                                          A2U20_03445     94
                A2U21_08210          *pilN*          Type IV pilus biogenesis protein PilN                              bi                                          A2U20_03430     98
                A2U21_08215          *pilM*          Type IV pilus biogenesis protein PilM                              bi                                          A2U20_03425     98
                A2U21_08410          *pulJ*          Type II secretory pathway, component PulJ                          bi                                          A2U20_03220     96
                A2U21_08415          *pulG*          Type II secretory pathway, pseudopilin PulG                        bi                                          A2U20_03215     97
                A2U21_08925          *pilW*          Type IV pilus biogenesis/stability protein PilW                    bi                                          A2U20_02695     100
                A2U21_10845          *pilD*          Tfp pilus assembly pathway, fimbrial leader peptidase              bi                                          A2U20_07225     94
                A2U21_10850          *pilC*          Type IV fimbrial assembly protein PilC                             bi                                          A2U20_07220     99
                A2U21_10855          *pilB*          Type IV fimbrial assembly ATPase PilB                              bi                                          A2U20_07215     98
                A2U21_10860          *pilA*          Type IV pilin PilA                                                 bi                                          A2U20_07210     87
  Hemolysin     A2U21_00465                          Putative hemagglutinin/hemolysin-related protein                   \-                                                          
                A2U21_00470          *prtB*          Serralysin B, hemolysin-type calcium-binding region                bi                                          A2U20_10970     69
                A2U21_02620          *ahpA*          Hemolysin regulation protein AhpA                                  bi                                          A2U20_09890     99
                A2U21_04100          *osmY*          Osmotically-inducible protein OsmY_putative hemolysin              bi                                          A2U20_08375     100
                A2U21_11130          *shlB1*         Hemolysin transporter protein ShlB                                 \-                                                          
                A2U21_11135          *shlB2*         Hemolysin transporter protein ShlB                                 bi                                          A2U20_08300     53
                A2U21_11140                          putative hemolysin                                                 \-                                                          
                A2U21_11145                          Putative hemolysin                                                 \-                                                          
                A2U21_11150          *hpmA*          Hemolysin                                                          \-                                                          
  *Secretion*   A2U21_02375                          Periplasmic/secreted protein                                       bi                                          A2U20_09675     93
                A2U21_08050          *esiB*          Putative secretory immunoglobulin A-binding protein                \-                                                          
                A2U21_08055          *esiB2*         Putative secretory immunoglobulin A-binding protein                bi                                          A2U20_01865     51
  Toxin         A2U21_00565          *hipA*          Serine/threonine-protein kinase toxin HipA                         bi                                          A2U20_10565     99
                A2U21_00620          *ebgC*          EbgC protein_Toxin-antitoxin biofilm protein TabA                  bi                                          A2U20_00255     98
                A2U21_00970          *hicB*          Antitoxin HicB                                                     bi                                          A2U20_10085     100
                A2U21_00995          *higA*          Antitoxin HigA_mRNA interferase antitoxin                          bi                                          A2U20_10110     98
                A2U21_01000          *higB*          mRNA interferase toxin HigB                                        bi                                          A2U20_10115     99
                A2U21_02950          *hicA*          Addiction module toxin HicA                                        bi                                          A2U20_03635     94
                A2U21_03035          *relE*          Addiction module toxin RelE                                        bi                                          A2U20_02840     59
                A2U21_03130          *pezT*          Antitoxin/toxin system zeta toxin                                  bi                                          A2U20_07065     75
                A2U21_03940                          Toxin-antitoxin system, antitoxin component                        \-                                                          
                A2U21_04275          *pasI*          Persistence and stress-resistance antitoxin PasI                   bi                                          A2U20_08515     98
                A2U21_04650          *higA2*         Antitoxin HigA_mRNA interferase antitoxin                          uni                                         A2U20_01495     54
                A2U21_04705          *hicA2*         Addiction module toxin HicA                                        bi                                          A2U20_05690     62
                A2U21_04735          *hicA3*         Addiction module toxin HicA                                        uni                                         A2U20_03635     94
                A2U21_04850          *relE*          mRNA interferase toxin RelE                                        \-                                                          
                A2U21_05325          *higB2*         mRNA interferase toxin HigB                                        bi                                          A2U20_06625     99
                A2U21_05330          *higA3*         Antitoxin HigA_mRNA interferase antitoxin                          bi                                          A2U20_06620     93
                A2U21_05725          *relE2*         Addiction module toxin RelE                                        \-                                                          
                A2U21_05930          *hicB2*         Antitoxin HicB                                                     \-                                                          
                A2U21_06130          *higA4*         Antitoxin HigA_mRNA interferase antitoxin                          bi                                          A2U20_05030     98
                A2U21_06135          *higB3*         mRNA interferase toxin HigB                                        bi                                          A2U20_05035     99
                A2U21_06150          *tabA*          Putative Toxin-antitoxin biofilm protein TabA                      bi                                          A2U20_05585     100
                A2U21_06185          *chpS*          Antitoxin                                                          bi                                          A2U20_05555     99
                A2U21_06190          *pemK*          Programmed cell death toxin PemK                                   bi                                          A2U20_05550     97
                A2U21_06245          *higA5*         Antitoxin HigA_mRNA interferase antitoxin                          bi                                          A2U20_05460     100
                A2U21_06250          *higB4*         mRNA interferase toxin HigB                                        bi                                          A2U20_05455     99
                A2U21_06305          *higB5*         mRNA interferase toxin HigB                                        bi                                          A2U20_05390     100
                A2U21_06310          *higA6*         Antitoxin HigA_mRNA interferase antitoxin                          bi                                          A2U20_05385     99
                A2U21_06560          *cdtA*          Toxin                                                              bi                                          A2U20_04835     99
                A2U21_06565          *cdtB*          Cytolethal distending toxin subunit CdtB                           bi                                          A2U20_05125     96
                A2U21_06570          *cdtC*          Toxin                                                              bi                                          A2U20_04825     99
                A2U21_06840          *cdtA2*         Toxin                                                              uni                                         A2U20_04835     99
                A2U21_06845          *cdtB2*         Cytolethal distending toxin subunit CdtB                           uni                                         A2U20_04830     94
                A2U21_06850          *cdtC2*         Toxin                                                              uni                                         A2U20_04825     94
                A2U21_08015          *relE3*         Addiction module toxin RelE                                        \-                                                          
                A2U21_08020          *stbD*          RelB/StbD replicon stabilization protein; antitoxin to RelE/StbE   \-                                                          
                A2U21_08785          *tdeA*          Putative memebrane toxin/ drug export protein A                    bi                                          A2U20_02805     97
                A2U21_08910          *higB6*         mRNA interferase toxin HigB                                        bi                                          A2U20_02710     96
                A2U21_08915          *higA7*         Antitoxin HigA_mRNA interferase antitoxin                          bi                                          A2U20_02705     93
                A2U21_09500          *hipA2*         Toxin HipA                                                         bi                                          A2U20_02115     95
                A2U21_09900          *vapD*          Virulence-associated protein D; endoribonuclease                   \-                                                          
                A2U21_10000          *vapC*          VapC toxin family PIN domain ribonuclease                          bi                                          A2U20_01850     78
  Other         A2U21_03770          *sodA*          Superoxide dismutase                                               bi                                          A2U20_07890     100
                A2U21_04050          *sodC*          Superoxide dismutase                                               bi                                          A2U20_08325     92
                A2U21_06535          *sirB*          Invasion protein expression up-regulator SirB                      bi                                          A2U20_05155     100
                A2U21_06540          *sirA*          Regulator of disulfide bond formation                              bi                                          A2U20_05150     99
                A2U21_08285          *vacJ*          putative VacJ lipoprotein                                          bi                                          A2U20_03355     97
                A2U21_09640          *espP*          Putative serine protease                                           bi                                          A2U20_01715     78
                A2U21_09655          *espP2*         Putative serine protease                                           bi                                          A2U20_01700     75
                A2U21_11540          *nanH*          Sialidase                                                          bi                                          A2U20_00515     99

^a^ The Hit column contains a \'-\' (no hit), \'uni\' or \'bi\' RAST server results from a one-to-one BLASTP comparison of the protein coding sequences in the Nagasaki genome using the D74 genome as the reference. "bi" represents a bidirectional best hit in which the reverse hit from the Nagasaki comparison genome to the D74 reference genome was also the best hit. "uni" indicates a uni-directional hit in which the reverse hit from the comparison genome to the reference genome was not also the best hit. "-"indicates no hit or match was found.

^b^Global pairwise nucleotide percent sequence identity.

Eight CDSs encoding predicted hemolysins were identified in D74 including two (locus tags A2U20_06885 and A2U20_07380) unique to strain D74 ([Table 3](#pone.0205700.t003){ref-type="table"}). D74 harbors two putative Serralysin B genes, *prtB* and *prtB2*, and a putative Serralysin C gene *prtC*. In contrast, only putative Serralysin B gene *prtB* was identified in strain Nagasaki ([Table 4](#pone.0205700.t004){ref-type="table"}). A notable size difference appears to exist between the proteins encoded by both *prtB*, *prtB2*, *and prtC* in D74, 1,954, 1,703, and 1,911 amino acids respectively, compared to the putative Serralysin B 910 amino acid protein encoded by *prtB* in Nagasaki. Nine CDSs encoding predicted hemolysins were identified in Nagasaki, five of which were identified as unique to Nagasaki. These include *hpmA* (A2U21_11150) and locus-tags A2U21_00465, A2U21_11140, and A2U210_11145. Nagasaki harbors two putative hemolysin transporter genes *shlB1* and *shlB2* (chromosomally located next to each other), while D74 contains only *shlB1* gene (Tables [3](#pone.0205700.t003){ref-type="table"} and [4](#pone.0205700.t004){ref-type="table"}). A notable size difference was also observed for the *shlB* gene in D74 encoding a putative 582 amino acid protein compared to the putative 329 amino acid protein encoded by the *shlB* in Nagasaki.

Two CDSs encoding genes predicted to function in secretion were identified in D74, A2U20_09675 and *esiB*, a putative secretory immunoglobulin A-binding encoding gene, while three were identified in Nagasaki. These include A2U21_02375 and two putative secretory immunoglobulin A-binding encoding genes *esiB* and *esiB2*, chromosomally located next to each other.

Thirty-nine CDSs encoding predicted toxins were identified in D74 and forty-six CDSs encoding predicted toxins were identified in Nagasaki. A noticeable difference between the CDSs encoding predicted toxins identified in D74 and Nagasaki was the seven *cdiA* genes encoding putative contact-dependent growth inhibition toxin A harbored only in strain D74 ([Table 3](#pone.0205700.t003){ref-type="table"}). These *cdiA* genes harbored by D74 are discussed in more detail below.

Both strains harbored a large number of toxin-antitoxin (TA) systems. TA systems are small genetic elements comprised of two components, a stable protein toxin and its more labile antagonistic antitoxin, which can be a protein or non-coding RNA \[[@pone.0205700.ref052]\]. TA systems were originally identified as plasmid-borne loci, which functioned to promote plasmid maintenance by killing daughter cells that lacked the TA encoded plasmid \[[@pone.0205700.ref052]\]. TA loci were subsequently discovered in numerous bacterial and archaeal chromosomes and provide several functions, such as stabilization of genomic regions, anti-addiction against similar plasmid-borne toxins, defense against phage infection, biofilm formation, control of the stress response, and bacterial persistence \[[@pone.0205700.ref052]--[@pone.0205700.ref054]\]. Six types of TA systems (types I to VI) have been described to date based on the type (either RNA or protein) and mode of action of the antitoxin \[[@pone.0205700.ref053]\]. The Type II TA system is highly abundant among prokaryotes and has been extensively studied \[[@pone.0205700.ref052], [@pone.0205700.ref054]--[@pone.0205700.ref056]\]. In type II TA systems, both toxin and antitoxin are small proteins encoded by genes in a bicistronic operon \[[@pone.0205700.ref052], [@pone.0205700.ref054]--[@pone.0205700.ref056]\]. The antitoxin blocks the toxicity of the toxin by forming a complex with it \[[@pone.0205700.ref052], [@pone.0205700.ref054]--[@pone.0205700.ref056]\]. Both D74 and Nagasaki contain several Type II TA families including *relBE*, *mazEF*, *vapBC*, and *higBA*, which was the most abundant with 10 putative *higBA* loci identified in D74 and 6 putative *higBA* loci identified in Nagasaki, with a varying degree of similarity ([Table 3](#pone.0205700.t003){ref-type="table"} and [Table 4](#pone.0205700.t004){ref-type="table"}).

Eight orthologs of other virulence-associated proteins were identified in both strains ([Table 3](#pone.0205700.t003){ref-type="table"} and [Table 4](#pone.0205700.t004){ref-type="table"}). A 75% sequence identity was observed between corresponding orthologs *espP* (A2U20_01700) in D74 and *espP2* (A2U21_09655) in Nagasaki and a 78% sequence identity was observed between corresponding orthologs *espP2* (A2U20_01715) in D74 and *espP* (A2U21_09640) in Nagasaki ([Table 3](#pone.0205700.t003){ref-type="table"} and [Table 4](#pone.0205700.t004){ref-type="table"}). Additionally a notable size difference was also observed for the putative proteins encoded by *espP* (A2U20_01700), 1,071 amino acids, and *espP2* (A2U20_01715), 985 amino acids, in D74, compared to the putative proteins encoded by *espP* (A2U21_09640), 781 amino acids, and *espP2* (A2U21_09655), 772 amino acids, in Nagasaki.

*cdiA* genes encoding putative contact-dependent growth inhibition proteins identified in *H*. *parasuis* D74 {#sec019}
-------------------------------------------------------------------------------------------------------------

Contact-dependent growth inhibition (CDI) is a process used by Gram-negative bacteria to deliver diverse growth inhibiting nuclease toxins into the cytoplasm of neighboring cells upon cell-cell contact \[[@pone.0205700.ref057]--[@pone.0205700.ref061]\]. CDI is mediated by the CdiB and CdiA proteins, which are members of the TpsB and TpsA two-partner secretion (TPS) group of proteins \[[@pone.0205700.ref061]--[@pone.0205700.ref063]\]. CdiB facilitates secretion of the CdiA "exoprotein" onto the cell surface \[[@pone.0205700.ref061], [@pone.0205700.ref064]\]. CdiA then binds to specific outer-membrane receptors on susceptible bacteria and transfers its C-terminal toxin domain (CdiA-CT) into the target cell \[[@pone.0205700.ref058]--[@pone.0205700.ref061]\]. CDI+ bacteria also produce small immunity proteins (CdiI) that protect them from toxin delivered by neighboring cells of closely related species or sibling cells by binding to the CdiA-CT and neutralizing its toxin activity \[[@pone.0205700.ref058]--[@pone.0205700.ref061]\].

The putative *cdiA* genes in strain D74 are located in three regions with a *cdiBAI* organization with "orphan" *cdiA* genes located downstream, which is similar to the organization found in *E*. *coli* strains and other gamma-proteobacteria \[[@pone.0205700.ref061], [@pone.0205700.ref065]\]. Region one includes *cdiA* (A2U20_05480) and five upstream potential *cdiI* candidate genes (locus tags A2U20_05485-A2U20_05505) ([Fig 3A](#pone.0205700.g003){ref-type="fig"}). The second region encompasses *fhaC* (A2U20_06825) located upstream of *cdiA2* (A2U20_06830), which, consistent with other TpsB proteins, shares substantial homology with CdiB ([Fig 3A](#pone.0205700.g003){ref-type="fig"}) \[[@pone.0205700.ref066]\]. Nine potential *cdiI* candidate genes (locus tags A2U20_06835-A2U20_06845, A2U20_06855-A2U20_06860, A2U20_06870, and A2U20_06880-A2U20_06890) and *cdiA3*, *cdiA4*, and *cdiA5* (locus tags A2U20_06850, A2U20_06865, A2U20_06875) are located downstream of *cdiA2*. Genes *cdiA3*, *cdiA4*, and *cdiA5* were identified as "orphan" *cdiA* genes based on their shared characteristics such as smaller size compared to larger full-length *cdiA* genes and resemble the 3'-ends of larger *cdiA* genes. ([Fig 3A](#pone.0205700.g003){ref-type="fig"}) \[[@pone.0205700.ref065]\]. The third region contains the *cdiA7* (A2U20_08295) gene with the *shlB* gene (A2U20_08300) gene located upstream ([Fig 3](#pone.0205700.g003){ref-type="fig"}). Similar to FhaC and other TpsB proteins, ShlB shares substantial homology with CdiB \[[@pone.0205700.ref066]\]. A potential *cdiI* candidate (A2U20_08290), followed by two potential "orphan" *cdiA* genes, *cdiA6* (A2U20_08285) and a predicted pseudogene *fha* (A2U20_08280), followed by two potential *cdiI* candidate genes (locus tags A2U20_08270 and A2U20_08265) are located downstream of *cdiA7* ([Fig 3A](#pone.0205700.g003){ref-type="fig"}).

![*cdiA* genes encoding putative contact-dependent growth inhibition proteins identified in *H*. *parasuis* D74.\
(A) Organization of *cdi* loci in D74. The three genomic regions containing putative *cdiA* genes are depicted. Gene function was assigned based on the results of BLASTX searches. Each arrow represents a gene within the locus; direction of the arrow indicates orientation within the closed genome sequence. Dark blue arrows represent the *cdiA* genes, red arrows represent *cdiB* homologues, light blue arrows represent potential "orphan" *cdiA* genes, yellow arrows represent putative *cdiI* candidates, and grey arrows represent genes predicted to have functions relating to horizontal gene transmission, black arrows represent genes whose predicted function is unrelated to contact-dependent inhibition. Genomic regions are not shown to scale. (B) Domain architecture of the predicted CdiA proteins. Domain content of the CdiA proteins was determined using a pfam database search. Grey boxes represent ESPR signal peptide domains (PF13018), green boxes represent Haemagg_act domains (PF05860), light blue boxes represent Fil_haemagg domains (PF05594), orange boxes represent Fil_haemagg_2 domains (PF13332), red boxes represent PT-VENN domains (PF04829), and purple boxes represent EndoU_bacteria domains (PF14436).](pone.0205700.g003){#pone.0205700.g003}

CdiA proteins share a number of characteristics in common with the TpsA family protein FHA \[[@pone.0205700.ref061], [@pone.0205700.ref067]\]. CdiA proteins typically contain an N-terminal region homologous to FHA containing the TPS domain required for interaction with the TpsB partner, CdiB or FhaC respectively, and haemagglutinin repeats that are predicted to form a β-helical structure \[[@pone.0205700.ref061], [@pone.0205700.ref067]\]. In addition, most *cdiA* homologues encode the VENN peptide motif, which delineates the beginning of C-terminal toxin domain as well as the conserved and variable regions \[[@pone.0205700.ref061], [@pone.0205700.ref067]\]. The predicted proteins encoded by the *cdiA* genes in D74 were evaluated for the presence of these domains. Domains identified in CdiA include a ESPR signal peptide domain (PF13018) required for export and multiple haemaglutination activity domains, specifically one Haemagg_act domain (PF05860), seven Fil_haemagg domains (PF05594), two Fil_haemagg_2 domains (PF13332) ([Fig 3B](#pone.0205700.g003){ref-type="fig"}). CdiA2 is similar to CdiA and contains a ESPR signal peptide domain (PF13018) required for export and multiple haemaglutination activity domains, including one Haemagg_act domain (PF05860), ten Fil_haemagg domains (PF05594), two Fil_haemagg_2 domains (PF13332) ([Fig 3B](#pone.0205700.g003){ref-type="fig"}). CdiA3 and CdiA6 are similar to each other and contain a pre-toxin domain with VENN motif that marks the beginning of the C-terminal toxin domain similar to other previously reported CdiA proteins ([Fig 3B](#pone.0205700.g003){ref-type="fig"}). CdiA4 and CdiA5 are also similar to each other and both contain a Fil_haemagg_2 domain (PF13332) ([Fig 3B](#pone.0205700.g003){ref-type="fig"}). CdiA7 is the largest CdiA protein in D74 and contains a ESPR signal peptide domain (PF13018) required for export and multiple haemaglutination activity domains, including one Haemagg_act domain (PF05860), thirteen Fil_haemagg domains (PF05594), two Fil_haemagg_2 domains (PF13332), a pre-toxin VENN domain (PF04829), and a EndoU_bacterial nuclease domain (PF14436) ([Fig 3B](#pone.0205700.g003){ref-type="fig"}). Overall, *cdiA3*, *cdiA4*, *cdiA5*, and *cdiA6* are similar to previously reported \"orphan\" *cdiA* genes as they encode much smaller proteins that lack a conserved export signal and other functional domains. The region containing the orphan *cdiA* genes was further evaluated and no additional cdi-related protein domains were found beyond those depicted in [Fig 3B](#pone.0205700.g003){ref-type="fig"} for CdiA3, CdiA4, CdiA5, and CdiA6. This indicates that the orphan *cdiA* genes are not the result of frameshift or indel mutations causing disruption of a larger intact *cdiA* gene(s). This genomic organization of a *cdi* locus containing one or more orphan *cdiA* genes downstream of full-length *cdiA* is common in many species of bacteria \[[@pone.0205700.ref065]\]. In contrast, CdiA, CdiA2, and CdiA7 are larger and contain most of the functional domains harbored by previously characterized CdiA-CT proteins; however, CdiA7 shares more similarity to other CdiA-CT proteins in that it additionally contains a PT-VENN motif and a recognizable nuclease domain at C-terminus.

*vtaA* family of trimeric autotransporter genes identified in *H*. *parasuis* strains D74 and Nagasaki {#sec020}
------------------------------------------------------------------------------------------------------

Pina et al. first identified thirteen proteins encoded by the *vtaA* family of trimeric autotransporter genes in strain Nagasaki based on the occurrence of a C-terminal YadA anchor domain, which defines this family of proteins \[[@pone.0205700.ref015]\]. That study also identified 17 homologues harbored by other *H*. *parasuis* strains with relatively conserved sequence within the passenger domain among *vtaA* homologues from pathogenic isolates and a high degree of divergence among non-virulent isolates \[[@pone.0205700.ref015]\]. The authors subsequently named these genes *vtaA* or virulence-associated trimeric autotransporter genes and classified the proteins encoded by *vtaA* genes into three groups based on sequence comparison of the C-terminal YadA anchor domain, with groups 1 and 2 being strongly associated with virulent *H*. *parasuis* isolates \[[@pone.0205700.ref015]\]. Previous studies have demonstrated that VtaA proteins are involved in virulence as well as being immunogenic, are produced during an infection, and are capable of conferring protection \[[@pone.0205700.ref068]--[@pone.0205700.ref070]\]. Recently, a comparison between the D74 and Nagasaki draft genomes identified only three *vtaA* genes harbored by D74 compared to thirteen harbored by Nagasaki \[[@pone.0205700.ref034]\]. Unfortunately, many *vtaA* genes identified within each strain were incomplete in the draft sequences, preventing a reliable one-to-one assignment of the *vtaA*-like ORFs to specific *vtaA* genes and subsequent evaluation of the predicted protein structure.

To ensure identification of all potential *vtaA* genes, all protein coding sequences in Nagasaki and D74 were searched for the occurrence of a YadA anchor domain and no additional YadA anchor domain containing proteins were identified. The 13 *vtaA* genes identified in Nagasaki have been named according to their location along the chromosome and are listed in [Table 5](#pone.0205700.t005){ref-type="table"} along with their respective name and group originally assigned by Pina et al. \[[@pone.0205700.ref015]\]. Similarly, the 3 *vtaA* genes identified in D74 have been named according to their location along the chromosome and are also listed in [Table 5](#pone.0205700.t005){ref-type="table"}. The predicted protein structure of all VtaA proteins for both Nagasaki and D74 were evaluated for known domain content ([Fig 4](#pone.0205700.g004){ref-type="fig"}). All Nagasaki VtaA proteins contain an N-terminal extended signal peptide or ESPR domain (PF13018) for Type V secretion, followed by 1--4 YadA head domains (PF05658), and 3--5 YadA anchor domains (PF03895). This region containing the head and stalk domains is referred to as the passenger domain region \[[@pone.0205700.ref071]\]. Following the passenger domain region, all Nagasaki VtaA proteins contain 2--8 collagen triple helix repeat domains (PF01391) followed by the C-terminal YadA anchor domain (PF03895) ([Fig 4A](#pone.0205700.g004){ref-type="fig"}). In contrast, none of the D74 VtaA proteins contain a collagen triple helix repeat domain (PF01391) and the predicted size for both VtaA_D1 (4054 AA) and VtaA_D2 (6778 AA) proteins is substantially larger than any predicted Nagasaki VtaA protein ([Fig 4B](#pone.0205700.g004){ref-type="fig"}). Additionally, VtaA_D3 differs from VtaA_D1 and VtaA_D2 proteins. VtaA_D3 contains a tryptophan-ring motif domain or TAA-Trp-ring (PF15401) and does not contain an N-terminal ESPR domain (PF13018) ([Fig 4B](#pone.0205700.g004){ref-type="fig"}). The absence of the ESPR domain suggests that VtaA_D3 may not be exported across the inner membrane. When we compared our VtaA predicted protein sequences to those reported by Pina et al. \[[@pone.0205700.ref015]\] two differences were identified and the other 11 out of 13 sequences were found to be 100% identical. The two differences identified were an amino acid change in VtaA_N9 (S1191G) relative to the previously reported sequence and an 18 amino acid insertion (AGPTGPQGPAGPTGSQDP) after amino acid 737 of VtaA8 that is not present in our VtaA_N4 sequence. The absence or presence of the insertion is located within the third collagen repeat domain and does not affect the presence or absence of this domain nor the total number of collagen repeat domains predicted for the two proteins.

![Domain architecture of the predicted VtaA proteins in *H*. *parasuis* strains D74 and Nagasaki.\
(A) Domain architecture of the predicted VtaA proteins from Nagasaki. Assigned gene name designations are shown at left. Schematic depictions of the 13 Nagasaki VtaA proteins is shown. The domains were identified by a pfam database search. ESPR signal peptides (PF13018) are shown in purple, YadA head domains (PF05658) in red, YadA stalk domains (PF05662) in blue, YadA anchor domains (PF03895) in green, collagen domains (PF1391) in orange, TAA-Trp-ring domains (PF15401) in yellow. (B) Domain architecture of the predicted VtaA proteins from D74. Assigned gene name designations are shown at left. Schematic depictions of the pfam domains, colored as in Panel A, for the 3 VtaA proteins from D74.](pone.0205700.g004){#pone.0205700.g004}

10.1371/journal.pone.0205700.t005

###### *vtaA* genes identified in *H*. *parasuis* Nagasaki.

![](pone.0205700.t005){#pone.0205700.t005g}

  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Nagasaki\     Nagasaki\   Name assigned by Pina et al. \[[@pone.0205700.ref015]\]   Group assigned by Pina et al. \[[@pone.0205700.ref015]\]   Hit[^a^](#t005fn001){ref-type="table-fn"}   D74\          D74 Name   \% Identity[^b^](#t005fn002){ref-type="table-fn"}
  locus_tag     Name                                                                                                                                                                         locus_tag                
  ------------- ----------- --------------------------------------------------------- ---------------------------------------------------------- ------------------------------------------- ------------- ---------- ---------------------------------------------------
  A2U21_00055   vtaA_N1     vtaA1                                                     1                                                          \-                                                                   0

  A2U21_00360   vtaA_N2     vtaA10                                                    2                                                          uni                                         A2U20_04585   vtaA_D1    49.73

  A2U21_00905   vtaA_N3     vtaA4                                                     1                                                          \-                                                                   0

  A2U21_03315   vtaA_N4     vtaA8[^**c**^](#t005fn003){ref-type="table-fn"}           1                                                          bi                                          A2U20_05995   vtaA_D3    36.84

  A2U21_04400   vtaA_N5     vtaA9                                                     1                                                          uni                                         A2U20_04585   vtaA_D1    30.74

  A2U21_05305   vtaA_N6     vtaA6                                                     1                                                          \-                                                                   0

  A2U21_05400   vtaA_N7     vtaA2                                                     1                                                          \-                                                                   0

  A2U21_05640   vtaA_N8     vtaA11                                                    2                                                          uni                                         A2U20_04585   vtaA_D1    50.94

  A2U21_06175   vtaA_N9     vtaA3[^**d**^](#t005fn004){ref-type="table-fn"}           1                                                          \-                                                                   0

  A2U21_06350   vtaA_N10    vtaA12                                                    1                                                          bi                                          A2U20_04585   vtaA_D1    94.09

  A2U21_07110   vtaA_N11    vtaA13                                                    1                                                          uni                                         A2U20_04585   vtaA_D1    59.87

  A2U21_08125   vtaA_N12    vtaA5                                                     3                                                          \-                                                                   0

  A2U21_09355   vtaA_N13    vtaA7                                                     3                                                          \-                                                                   0
  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

^a^ The Hit column contains a \'-\' (no hit), \'uni\' or \'bi\' RAST server results from a one-to-one BLASTP comparison of the protein coding sequences in the D74 genome using the Nagasaki genome as the reference. "bi" represents a bidirectional best hit in which the reverse hit from the D74 comparison genome to the Nagasaki reference genome was also the best hit. "uni" represents uni-directional indicates a hit in which the reverse hit from the comparison genome to the reference genome was not also the best hit. "-"indicates no hit or match was found.

^b^Local percent sequence identity.

^c^18 amino acid insertion compared to the Pina et al. \[[@pone.0205700.ref015]\] sequence.

^d^ Single amino acid difference at position 1191.

When the genome regions in Nagasaki and D74 were compared, the sequence and gene content up and downstream of the *vtaA* gene locations in Nagasaki were similar to the reciprocal locations in D74. No evidence of extensive genome rearrangement at these locations was observed. A different gene or genes were identified in D74 at the same location of a reciprocal *vtaA* gene in Nagasaki, which could have arisen from small insertion events. Further evaluation of the *vtaA* genes in both strains suggested that they are not in an operon configuration. Pina et al. identified an active promoter upstream of *vtaA*\_N3 \[[@pone.0205700.ref015]\]. *In silico* analysis indicated that the upstream region of all 13 Nagasaki *vtaA* genes contained highly similar promoter sequences to the *vtaA*\_N3 promoter. A highly similar promoter sequence to the *vtaA*\_N3 was additionally observed upstream of *vtaA*\_D2 in D74. This sequence conservation implies similar expression and/or regulation mechanisms among these genes.

Methylation motifs and RM-systems in *H*. *parasuis* strains D74 and Nagasaki {#sec021}
-----------------------------------------------------------------------------

In bacteria, the most common post-replicative modification of DNA is methylation by methyltransferase (MTase) enzymes resulting in three types of epigenetic markers: N6-methyladenine (m6A), N4-methylcytosine (m4C) and 5-methylcytosine (m5C) \[[@pone.0205700.ref047], [@pone.0205700.ref072]\]. DNA methylation serves several key roles in bacterial processes, including mismatch repair, the timing of DNA replication, conferring protection against bacteriophages, and regulating gene expression. \[[@pone.0205700.ref073]--[@pone.0205700.ref078]\]. Analysis of the SMRT DNA sequencing kinetics was used to identify total base modifications in the genomes of *H*. *parasuis* D74 and Nagasaki, and the modified sequence motifs for each strain are summarized in Tables [6](#pone.0205700.t006){ref-type="table"} and [7](#pone.0205700.t007){ref-type="table"}.

10.1371/journal.pone.0205700.t006

###### Methylation motifs detected in *H*. *parasuis* D74.

![](pone.0205700.t006){#pone.0205700.t006g}

  Motif[^a^](#t006fn001){ref-type="table-fn"}   Modification Type                                     \# Detected   \# in Genome   \% Detected   Mean Modification QV   Mean Motif Coverage   Partner Motif
  --------------------------------------------- ----------------------------------------------------- ------------- -------------- ------------- ---------------------- --------------------- ----------------
  `AGCNNNNNGCT`                                 m6A                                                   767           772            99.4%         535.6                  376.2                 `AGCNNNNNGCT`
  `GTANNNNNNTGG`                                m6A                                                   817           825            99.0%         436.6                  380.3                 `CCANNNNNNTAC`
  `CCANNNNNNTAC`                                m6A                                                   813           825            98.5%         421.3                  381.9                 `GTANNNNNNTGG`
  `AAGCTT`                                      m6A                                                   623           630            98.9%         442.4                  384.0                 `AAGCTT`
  `GATC`                                        m6A                                                   15,534        15,718         98.8%         410.7                  381.5                 `GATC`
  `GTAHNNNNNNCTTG`                              m6A                                                   217           220            98.6%         420.1                  378.9                 
  `CAAGNNNNNGNTAC`                              m6A                                                   55            57             96.5%         397.1                  348.8                 
  `AGCNNNNGGATC`                                m6A                                                   47            55             85.5%         346.8                  365.8                 
  `GCAGGVNNDG`                                  m6A                                                   316           659            48.0%         99.1                   382.2                 
  `VAAGCTCKD`                                   m6A                                                   207           447            46.3%         131.9                  391.1                 
  `AHBYAGYAD`                                   m6A                                                   662           2,632          25.2%         108.6                  376.7                 
  `DDTGTNDNDG`                                  modified_base[^b^](#t006fn002){ref-type="table-fn"}   1,575         8,346          18.9%         52.3                   356.8                 
  `TNNNNNNH`                                    modified_base[^b^](#t006fn002){ref-type="table-fn"}   179,073       1,197,696      15.0%         52.7                   367.5                 
  `DTNVVNDDG`                                   modified_base[^b^](#t006fn002){ref-type="table-fn"}   9,920         78,834         12.6%         48.6                   366.4                 
  `AGNNNNNH`                                    m6A                                                   15,854        200,853        7.9%          112.6                  371.8                 

^a^Bold underlined bases indicate methylated base in motif sequence.

^b^Base modification not identified or recognized by software.

10.1371/journal.pone.0205700.t007

###### Methylation motifs detected in *H*. *parasuis* Nagasaki.

![](pone.0205700.t007){#pone.0205700.t007g}

  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Motif[^a^](#t007fn001){ref-type="table-fn"}   Modification\                                         \#\        \# in Genome   \% Detected   Mean Modification QV   Mean Motif Coverage   Partner Motif
                                                Type                                                  Detected                                                                             
  --------------------------------------------- ----------------------------------------------------- ---------- -------------- ------------- ---------------------- --------------------- ------------------
  `AAGNNNNNCTT`                                 m6A                                                   1,322      1,324          99.8%         719.7                  571.6                 `AAGNNNNNCTT`

  `AACNNNNNTGG`                                 m6A                                                   1,089      1,092          99.7%         676.2                  592.7                 `CCANNNNNGTT`

  `CCANNNNNGTT`                                 m6A                                                   1,088      1,092          99.6%         700.0                  622.7                 `AACNNNNNTGG`

  `GTANNNNNNNCTTG`                              m6A                                                   217        218            99.5%         641.8                  610.1                 `CAAGNNNNNNNTAC`

  `CAAGNNNNNNNTAC`                              m6A                                                   215        218            98.6%         671.3                  582.9                 `GTANNNNNNNCTTG`

  `GATC`                                        m6A                                                   14,603     14,778         98.8%         602.6                  617.8                 `GATC`

  `AGGNNNNNCCT`                                 m6A                                                   454        460            98.7%         688.5                  590.4                 `AGGNNNNNCCT`

  `AAGVNNNNCTT`                                 m6A                                                   303        1,013          29.9%         130.6                  608.1                 

  `RAHDBAGYA`                                   m6A                                                   721        2,881          25.0%         107.0                  582.3                 

  `TNNNNNNH`                                    modified_base[^b^](#t007fn002){ref-type="table-fn"}   181,179    1,123,132      16.1%         58.7                   579.9                 

  `DDTNVVNDDG`                                  modified_base[^b^](#t007fn002){ref-type="table-fn"}   9,439      61,834         15.3%         54.8                   582.8                 

  `TSNNKNNG`                                    modified_base[^b^](#t007fn002){ref-type="table-fn"}   7,871      64,478         12.2%         52.9                   587.1                 

  `AGDNNNNH`                                    m6A                                                   11,510     134,477        8.6%          178.5                  591.9                 

  `BAGCNVNNH`                                   m6A                                                   1,133      24,217         4.7%          140.2                  629.3                 
  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

^a^Bold underlined bases indicate methylated base in motif sequence.

^b^Base modification not identified or recognized by software.

A total of 15 sequence motifs were identified in strain D74, and N6-methyladenine (m6A) was the most prevalent type of modification detected ([Table 6](#pone.0205700.t006){ref-type="table"}). Focusing on strain Nagasaki, a total of 14 recognition sites for methylation or sequence motifs were identified and, similar to D74, N6-methyladenine (m6A) was the most prevalent type of modification detected ([Table 7](#pone.0205700.t007){ref-type="table"}). This analysis revealed a surprising degree of diversity in motifs observed between these closely related strains given that the methylation motif `5’-GAm6TC-3’` was the only motif shared or observed in both D74 and Nagasaki ([Table 6](#pone.0205700.t006){ref-type="table"} and [Table 7](#pone.0205700.t007){ref-type="table"}).

The genomes of *H*. *parasuis* Nagasaki and D74 were assessed using the Restriction Enzyme Database REBASE ([www.rebase.neb.com](http://www.rebase.neb.com/)) \[[@pone.0205700.ref047]\] for determination of putative MTases involved with each motif and for comparisons with known modification systems. A total of 26 genes associated with restriction-modification systems were identified in *H*. *parasuis* D74, including 11 genes associated with Type 1 restriction-modification (RM) systems and 15 genes associated with Type II RM systems ([Table 8](#pone.0205700.t008){ref-type="table"}). Genes associated with Type III RM systems were not identified in D74 ([Table 8](#pone.0205700.t008){ref-type="table"}). REBASE predicted three recognition sequences corresponding to a specific motif detected by the SMRT sequencing analysis. REBASE analysis indicated that the putative Type I RM enzymes S.Hpa74III, Hpa74III, and M.Hpa74III were predicted to be responsible for the `5’-GTAm6NNNNNNNCTTG-3’` modification ([Table 8](#pone.0205700.t008){ref-type="table"}). The putative Type II RM enzymes M.Hpa74I and M.Hpa74IP were indicated by REBSE to be responsible for the motif 5'-A^m6^A GCTT-3'modification ([Table 8](#pone.0205700.t008){ref-type="table"}). The putative Type II RM enzyme *dam* or Hpa74II was predicted to be responsible for the 5'-GA^m6^TC-3'modification for D74 ([Table 8](#pone.0205700.t008){ref-type="table"}). The remaining two motifs detected by the SMRT sequencing analysis did not correspond with a REBASE predicted recognition sequence. Two putative Type II RM enzymes Hpa74ORFHP and M.Hpa74ORFHP were predicted by REBASE to recognize the sequence motif 5'-GGCC-3, which was not a motif detected by the SMRT sequencing analysis. Three putative RM enzyme genes identified in D74 by REBSAE analysis are predicted pseudogenes. These include S2.Hpa74ORFDP, Hpa74ORFJP, and M.Hpa74IP, associated with the Type II RM system indicated by REBSE to be responsible for the motif `5’-Am6A GCTT-3’`modification ([Table 8](#pone.0205700.t008){ref-type="table"}). In contrast, none of the putative RM enzymes genes identified in Nagasaki by REBASE analysis are predicted pseudogenes.

10.1371/journal.pone.0205700.t008

###### Putative *H*. *parasuis* D74 restriction modification systems.

![](pone.0205700.t008){#pone.0205700.t008g}

  Type[^a^](#t008fn001){ref-type="table-fn"}   Gene[^b^](#t008fn002){ref-type="table-fn"}   D74 locus_tag                                       D74 Name                                         Predicted Recognition Sequence   REBASE Name
  -------------------------------------------- -------------------------------------------- --------------------------------------------------- ------------------------------------------------ -------------------------------- ---------------
  I                                            M                                            A2U20_05240                                         hsdM                                                                              M.Hpa74ORFFP
  I                                            S                                            A2U20_05245                                         hsdS                                                                              S.Hpa74ORFFP
  I                                            R                                            A2U20_05260                                         hsdR2                                                                             Hpa74ORFFP
  I                                            R                                            A2U20_10200                                         hsdR3                                                                             Hpa74ORFIP
  I                                            S                                            A2U20_10215                                         hsdS2                                                                             S1.Hpa74ORFIP
  I                                            S                                            A2U20_10220                                         hypothetical protein CDS                                                          S2.Hpa74ORFIP
  I                                            M                                            A2U20_10230                                         hsdM2                                                                             M.Hpa74ORFIP
  I                                            R                                            A2U20_10460[^c^](#t008fn003){ref-type="table-fn"}   hsdR4[^c^](#t008fn003){ref-type="table-fn"}                                       Hpa74ORFJP
  I                                            S                                            A2U20_11315                                         hsdS3                                            `GTANNNNNNNCTTG`                 S.Hpa74III
  I                                            R                                            A2U20_11320                                         hsdR5                                            `GTANNNNNNNCTTG`                 Hpa74III
  I                                            M                                            A2U20_11330                                         hsdM3                                            `GTANNNNNNNCTTG`                 M.Hpa74III
  II                                           M                                            A2U20_00375                                         hindIIIM                                         `AAGCTT`                         M.Hpa74I
  II                                           R                                            A2U20_00380[^c^](#t008fn003){ref-type="table-fn"}   hindIIIR[^c^](#t008fn003){ref-type="table-fn"}   `AAGCTT`                         Hpa74IP
  II                                           RM                                           A2U20_00575                                         bcgIA                                                                             Hpa74ORFBP
  II                                           S                                            A2U20_00580                                         bcgIB                                                                             S.Hpa74ORFBP
  II                                           S                                            A2U20_00800                                         bcgIB                                                                             S1.Hpa74ORFDP
  II                                           S                                            A2U20_00805[^c^](#t008fn003){ref-type="table-fn"}   bcgIB2[^c^](#t008fn003){ref-type="table-fn"}                                      S2.Hpa74ORFDP
  II                                           M                                            A2U20_03405                                         dam                                              `GATC`                           Hpa74II
  II                                           RM                                           A2U20_07465                                         hypothetical protein CDS                                                          Hpa74ORFGP
  II                                           R                                            A2U20_07700                                         restriction endonuclease CDS                     `GGCC`                           Hpa74ORFHP
  II                                           M                                            A2U20_07705                                         haeIIIM                                          `GGCC`                           M.Hpa74ORFHP
  II                                           M                                            A2U20_10010                                         yhdJ                                                                              M.Hpa74ORFOP
  II                                           M                                            A2U20_10475                                         modification methylase CDS                                                        M.Hpa74ORFLP
  II                                           R                                            A2U20_10480                                         HNH endonuclease CDS                                                              Hpa74ORFLP
  II                                           S                                            A2U20_10485                                         bcgIB3                                                                            S.Hpa74ORFMP
  II                                           RM                                           A2U20_10490                                         bcgIA2                                                                            Hpa74ORFMP

^a^Systems were designated Type I, II, or III based on REBASE analyses.

^b^Gene designations of methylase (M), restriction (R), fused restriction-modification (RM), or specificity (S), along with predicted recognition sequence and REBASE name, were determined using REBASE analysis.

^C^Predicted pseudogene.

Focusing on *H*. *parasuis* Nagasaki, 34 genes associated with restriction-modification systems were identified, including 14 genes associated with Type 1, 15 genes associated with Type II, and 5 genes associated with Type III RM systems ([Table 9](#pone.0205700.t009){ref-type="table"}). Only two of the REBASE predicted recognition sequences corresponded to a specific motif detected by the SMRT sequencing analysis. REBASE analysis indicated that the putative Type I RM enzymes M.HpaNNII, HpaNNIIP, and S.HapNNII were predicted to be responsible for the `5’-GTAm6NNNNNNNCTTG-3’` modification ([Table 9](#pone.0205700.t009){ref-type="table"}). The putative Type II RM enzyme *dam* or M.HpaNNI was predicted to be responsible for the 5'-GA^m6^TC-3'modification ([Table 9](#pone.0205700.t009){ref-type="table"}). The remaining five motifs identified by the SMRT sequencing analysis represent yet unknown recognition sequences.

10.1371/journal.pone.0205700.t009

###### Putative *H*. *parasuis* Nagasaki restriction modification systems.

![](pone.0205700.t009){#pone.0205700.t009g}

  Type[^a^](#t009fn001){ref-type="table-fn"}   Gene[^b^](#t009fn002){ref-type="table-fn"}   Nagasaki locus_tag   Nagasaki Name                                          Predicted Recognition Sequence[^b^](#t009fn002){ref-type="table-fn"}   REBASE Name[^b^](#t009fn002){ref-type="table-fn"}
  -------------------------------------------- -------------------------------------------- -------------------- ------------------------------------------------------ ---------------------------------------------------------------------- ---------------------------------------------------
  I                                            M                                            A2U21_00095          hsdM                                                   `GTANNNNNNNCTTG`                                                       M.HpaNNII
  I                                            R                                            A2U21_00110          hsdR                                                   `GTANNNNNNNCTTG`                                                       HpaNNIIP
  I                                            S                                            A2U21_00115          hsdS                                                   `GTANNNNNNNCTTG`                                                       S.HpaNNII
  I                                            R                                            A2U21_01085          hsdR2                                                                                                                         HpaNNORFEP
  I                                            S                                            A2U21_01100          hsdS2                                                                                                                         S1.HpaNNORFEP
  I                                            S                                            A2U21_01105          hypothetical protein CDS                                                                                                      S2.HpaNNORFEP
  I                                            M                                            A2U21_01115          type I restriction-modification system subunit M CDS                                                                          M.HpaNNORFEP
  I                                            R                                            A2U21_04210          hsdR4                                                                                                                         HpaNNORFIP
  I                                            S                                            A2U21_04220          hsdS3                                                                                                                         S1.HpaNNORFEP
  I                                            S                                            A2U21_04225          hsdS4                                                                                                                         S2.HpaNNORFEP
  I                                            M                                            A2U21_04230          hsdM2                                                                                                                         M.HpaNNORFEP
  I                                            R                                            A2U21_06440          hsdR5                                                                                                                         HpaNNORFJP
  I                                            S                                            A2U21_06445          hsdS5                                                                                                                         S.HpaNNORFJP
  I                                            M                                            A2U21_06450          hsdM3                                                                                                                         M.HpaNNORFJP
  II                                           S                                            A2U21_00855          bcgIB                                                                                                                         S1.HpaNNORFDP
  II                                           S                                            A2U21_00860          bcgIB2                                                                                                                        S2.HpaNNORFDP
  II                                           RM                                           A2U21_00865          bcgIA                                                                                                                         HpaNNORFDP
  II                                           M                                            A2U21_03345          hypothetical protein CDS                                                                                                      M.HpaNNORFGP
  II                                           M                                            A2U21_03850          hhalM                                                  `GCGC`                                                                 M.HpaNNORFHP
  II                                           R                                            A2U21_03855          type II RM endonuclease                                `GCGC`                                                                 HpaNNORFHP
  II                                           M                                            A2U21_06885          hpaIIM                                                 `CCGG`                                                                 M.HpaNNORFAP
  II                                           M                                            A2U21_08235          dam                                                    `GATC`                                                                 M.HpaNNI
  II                                           M                                            A2U21_09040          bspRIM                                                 `CGCG`                                                                 M.HpaNNORFLP
  II                                           R                                            A2U21_09045          hypothetical protein CDS                               `CGCG`                                                                 HpaNNORFLP
  II                                           M                                            A2U21_09985          restriction endonuclease subunit M CDS                                                                                        M1.HpaNNORFMP
  II                                           M                                            A2U21_09990          restriction endonuclease CDS                                                                                                  M2.HpaNNORFMP
  II                                           RM                                           A2U21_09995          restriction endonuclease CDS                                                                                                  HpaNNORFMP
  II                                           M                                            A2U21_10160          hypothetical protein CDS                                                                                                      M.HpaNNORFNP
  II                                           M                                            A2U21_10520          hypothetical protein CDS                               `BA`                                                                   M.HpaNNORFOP
  III                                          M                                            A2U21_01380          restriction endonuclease subunit M CDS                 `GGAG`                                                                 M1.HpaNNORFFP
  III                                          M                                            A2U21_01385          bamHIM                                                 `GGAG`                                                                 M2.HpaNNORFFP
  III                                          R                                            A2U21_01390          type III restriction endonuclease subunit R CDS                                                                               HpaNNORFFP
  III                                          M                                            A2U21_11010          site-specific DNA-methyltransferase CDS                                                                                       M.HpaNNORFPP
  III                                          R                                            A2U21_11015          restriction endonuclease CDS                                                                                                  HpaNNORFPP

^a^Systems were designated Type I, II, or III based on REBASE analyses.

^b^Gene designations of methylase (M), restriction (R), fused restriction-modification (RM), or specificity (S), along with predicted recognition sequence and REBASE name, were determined using REBASE analysis.

Expression of MTases can undergo phase variation by slipped-strand mispairing due to the presence of simple sequence repeats (SSRs), such as homopolymeric tracts \[[@pone.0205700.ref079]--[@pone.0205700.ref083]\]. All of the putative RM genes identified in D74 ([Table 8](#pone.0205700.t008){ref-type="table"}) and Nagasaki ([Table 9](#pone.0205700.t009){ref-type="table"}) were search for the presence of SSRs within the coding region and in the region encompassing 150 bp upstream of the putative start codon. No SSRs were observed in the upstream region for five RM genes identified in D74 (A2U20_00805c, A2U20_10480, A2U20_10215, A2U20_11315, and A2U20_10200), while six homopolymeric tracts of consisting of five or more bases were observed in the upstream region of *hsdR2* (A2U20_05260) ([S6 Table](#pone.0205700.s006){ref-type="supplementary-material"}). SSRs were observed within the coding region of all of the D74 RM genes and the numbers of SSRs ranged from two (A2U20_00580 and A2U20_11330) to 38 (A2U20_07465) ([S6 Table](#pone.0205700.s006){ref-type="supplementary-material"}). No SSRs were observed in the upstream region for six RM genes identified in Nagasaki (A2U21_00115, A2U21_01085, A2U21_04210, A2U21_03345, A2U21_03850, A2U21_06885), while six homopolymeric tracts of consisting of five or more bases were observed in the upstream region of A2U21_09985 ([S7 Table](#pone.0205700.s007){ref-type="supplementary-material"}). SSRs were observed within the coding region of all of the Nagasaki RM genes and the numbers of SSRs ranged from two (A2U21_10520) to 31 (A2U21_04210 and A2U21_00110) ([S7 Table](#pone.0205700.s007){ref-type="supplementary-material"}). While further studies are warranted, the occurrence of these homopolymeric tracts within these regions indicates the potential of these genes to undergo phase variation by slip strand mispairing.

Conclusions {#sec022}
===========

This report provides the closed whole-genome sequence annotation and genome-wide methylation patterns for the *H*. *parasuis* non-virulent D74 strain and for the highly virulent Nagasaki strain. This collective information will enable reliable one-to-one assignment of specific genes of interest and subsequent evaluation of predicted protein structures. Highlights of the information gained from this study include the sequence and annotation of a plasmid harbored by strain D74 that shares a high degree of similarity to other plasmids harbored by members of the *Pasteurellaceae* family, which could prove useful in future allelic replacement and/or functional genomic studies. Evaluation of the virulence-associated genes contained within the genomes of D74 and Nagasaki led to the discovery of a large number of TA systems, primarily Type II TA families, within both genomes. Five predicted hemolysins were identified as unique to Nagasaki and seven putative contact-dependent growth inhibition toxin proteins were identified only in strain D74. Assessment of all potential *vtaA* genes revealed thirteen present in the Nagasaki genome and three in the D74 genome. Subsequent evaluation of the predicted protein structure revealed that none of the D74 VtaA proteins contain a collagen triple helix repeat domain and a much larger predicted amino acid size for two D74 VtaA proteins compared to any predicted Nagasaki VtaA protein. Fifteen methylation sequence motifs were identified in D74 and fourteen methylation sequence motifs were identified in Nagasaki using SMRT sequencing analysis. Only one of the methylation sequence motif was observed in both strains highlighting the diversity between D74 and Nagasaki. Subsequent analysis also revealed diversity in the restriction-modification systems harbored by D74 and Nagasaki. Our hope is that the assembly and annotation of these genomes, coupled with the comparative genomic analyses reported in this study, will aid in the identification of genetic elements that underlie and influence phenotypic differences between these isolates. Together, this information can support future research and the development of vaccines with improved efficacy towards *H*. *parasuis* in swine to decrease the prevalence and disease burden caused by this pathogen.
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